APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antigen Self Test Nasal

Compare research editions
View pricing & licenses

Selected research

Industry Research

Antigen Self Test Nasal Industry Research Report 2026

4 July 2026146 pages

Choose your research edition.

Industry ResearchAntigen Self Test Nasal Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Antigen Self Test Nasal Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Antigen Self Test Nasal Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antigen Self Test Nasal Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Antigen Self Test Nasal Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Antigen Self Test Nasal market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Antigen Self Test Nasal is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Antigen Self Test Nasal is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Antigen Self Test Nasal is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Antigen Self Test Nasal include Roche, Watsons, TEST SEA LAB, SD Biosensor, RapiGEN Inc., Rapid Labs Limited, Quidel, Princeton BioMeditech Corporation and Orient Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Antigen Self Test Nasal market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Antigen Self Test Nasal Market by Company

Roche

Watsons

TEST SEA LAB

SD Biosensor

RapiGEN Inc.

Rapid Labs Limited

Quidel

Princeton BioMeditech Corporation

Orient Gene

OraSure Technologies

LumiraDx

InBios

Heathershaws Compounding Pharmacy

Ellume

CTK Biotech

Clip Health

Celltrion

BioTeke Corporation

BGI

BD

Aidian Oy

ACCESS BIO

Abbott

Antigen Self Test Nasal Segment by Type

Colloidal Gold Immunochromatography

Latex Immunochromatography

Fluorescence Immunochromatography

Others

Antigen Self Test Nasal Segment by Application

Hospital

School

Family

Others

Antigen Self Test Nasal Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antigen Self Test Nasal market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antigen Self Test Nasal and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antigen Self Test Nasal.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Antigen Self Test Nasal manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Antigen Self Test Nasal by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Antigen Self Test Nasal in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antigen Self Test Nasal Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Antigen Self Test Nasal Sales (k units) of Manufacturers (2021-2026) Table 7. Global Antigen Self Test Nasal Sales Market Share by Manufacturers (2021-2026) Table 8. Global Antigen Self Test Nasal Revenue of Manufacturers (2021-2026) Table 9. Global Antigen Self Test Nasal Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Antigen Self Test Nasal Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Antigen Self Test Nasal Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Antigen Self Test Nasal, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Antigen Self Test Nasal, Product Type & Application Table 14. Global Antigen Self Test Nasal Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Antigen Self Test Nasal by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Roche Company Information Table 19. Roche Business Overview Table 20. Roche Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Roche Antigen Self Test Nasal Product Portfolio Table 22. Roche Recent Developments Table 23. Watsons Company Information Table 24. Watsons Business Overview Table 25. Watsons Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Watsons Antigen Self Test Nasal Product Portfolio Table 27. Watsons Recent Developments Table 28. TEST SEA LAB Company Information Table 29. TEST SEA LAB Business Overview Table 30. TEST SEA LAB Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. TEST SEA LAB Antigen Self Test Nasal Product Portfolio Table 32. TEST SEA LAB Recent Developments Table 33. SD Biosensor Company Information Table 34. SD Biosensor Business Overview Table 35. SD Biosensor Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. SD Biosensor Antigen Self Test Nasal Product Portfolio Table 37. SD Biosensor Recent Developments Table 38. RapiGEN Inc. Company Information Table 39. RapiGEN Inc. Business Overview Table 40. RapiGEN Inc. Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. RapiGEN Inc. Antigen Self Test Nasal Product Portfolio Table 42. RapiGEN Inc. Recent Developments Table 43. Rapid Labs Limited Company Information Table 44. Rapid Labs Limited Business Overview Table 45. Rapid Labs Limited Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Rapid Labs Limited Antigen Self Test Nasal Product Portfolio Table 47. Rapid Labs Limited Recent Developments Table 48. Quidel Company Information Table 49. Quidel Business Overview Table 50. Quidel Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Quidel Antigen Self Test Nasal Product Portfolio Table 52. Quidel Recent Developments Table 53. Princeton BioMeditech Corporation Company Information Table 54. Princeton BioMeditech Corporation Business Overview Table 55. Princeton BioMeditech Corporation Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Princeton BioMeditech Corporation Antigen Self Test Nasal Product Portfolio Table 57. Princeton BioMeditech Corporation Recent Developments Table 58. Orient Gene Company Information Table 59. Orient Gene Business Overview Table 60. Orient Gene Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Orient Gene Antigen Self Test Nasal Product Portfolio Table 62. Orient Gene Recent Developments Table 63. OraSure Technologies Company Information Table 64. OraSure Technologies Business Overview Table 65. OraSure Technologies Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. OraSure Technologies Antigen Self Test Nasal Product Portfolio Table 67. OraSure Technologies Recent Developments Table 68. LumiraDx Company Information Table 69. LumiraDx Business Overview Table 70. LumiraDx Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. LumiraDx Antigen Self Test Nasal Product Portfolio Table 72. LumiraDx Recent Developments Table 73. InBios Company Information Table 74. InBios Business Overview Table 75. InBios Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. InBios Antigen Self Test Nasal Product Portfolio Table 77. InBios Recent Developments Table 78. Heathershaws Compounding Pharmacy Company Information Table 79. Heathershaws Compounding Pharmacy Business Overview Table 80. Heathershaws Compounding Pharmacy Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Heathershaws Compounding Pharmacy Antigen Self Test Nasal Product Portfolio Table 82. Heathershaws Compounding Pharmacy Recent Developments Table 83. Ellume Company Information Table 84. Ellume Business Overview Table 85. Ellume Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Ellume Antigen Self Test Nasal Product Portfolio Table 87. Ellume Recent Developments Table 88. CTK Biotech Company Information Table 89. CTK Biotech Business Overview Table 90. CTK Biotech Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. CTK Biotech Antigen Self Test Nasal Product Portfolio Table 92. CTK Biotech Recent Developments Table 93. Clip Health Company Information Table 94. Clip Health Business Overview Table 95. Clip Health Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Clip Health Antigen Self Test Nasal Product Portfolio Table 97. Clip Health Recent Developments Table 98. Celltrion Company Information Table 99. Celltrion Business Overview Table 100. Celltrion Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Celltrion Antigen Self Test Nasal Product Portfolio Table 102. Celltrion Recent Developments Table 103. BioTeke Corporation Company Information Table 104. BioTeke Corporation Business Overview Table 105. BioTeke Corporation Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. BioTeke Corporation Antigen Self Test Nasal Product Portfolio Table 107. BioTeke Corporation Recent Developments Table 108. BGI Company Information Table 109. BGI Business Overview Table 110. BGI Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. BGI Antigen Self Test Nasal Product Portfolio Table 112. BGI Recent Developments Table 113. BD Company Information Table 114. BD Business Overview Table 115. BD Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. BD Antigen Self Test Nasal Product Portfolio Table 117. BD Recent Developments Table 118. Aidian Oy Company Information Table 119. Aidian Oy Business Overview Table 120. Aidian Oy Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Aidian Oy Antigen Self Test Nasal Product Portfolio Table 122. Aidian Oy Recent Developments Table 123. ACCESS BIO Company Information Table 124. ACCESS BIO Business Overview Table 125. ACCESS BIO Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. ACCESS BIO Antigen Self Test Nasal Product Portfolio Table 127. ACCESS BIO Recent Developments Table 128. Abbott Company Information Table 129. Abbott Business Overview Table 130. Abbott Antigen Self Test Nasal Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Abbott Antigen Self Test Nasal Product Portfolio Table 132. Abbott Recent Developments Table 133. Global Antigen Self Test Nasal Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global Antigen Self Test Nasal Sales by Region (2021-2026) & (k units) Table 135. Global Antigen Self Test Nasal Sales Market Share by Region (2021-2026) Table 136. Global Antigen Self Test Nasal Sales by Region (2027-2032) & (k units) Table 137. Global Antigen Self Test Nasal Sales Market Share by Region (2027-2032) Table 138. Global Antigen Self Test Nasal Revenue by Region (2021-2026) & (US$ Million) Table 139. Global Antigen Self Test Nasal Revenue Market Share by Region (2021-2026) Table 140. Global Antigen Self Test Nasal Revenue by Region (2027-2032) & (US$ Million) Table 141. Global Antigen Self Test Nasal Revenue Market Share by Region (2027-2032) Table 142. North America Antigen Self Test Nasal Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America Antigen Self Test Nasal Sales by Country (2021-2026) & (k units) Table 144. North America Antigen Self Test Nasal Sales by Country (2027-2032) & (k units) Table 145. North America Antigen Self Test Nasal Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Antigen Self Test Nasal Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe Antigen Self Test Nasal Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe Antigen Self Test Nasal Sales by Country (2021-2026) & (k units) Table 149. Europe Antigen Self Test Nasal Sales by Country (2027-2032) & (k units) Table 150. Europe Antigen Self Test Nasal Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Antigen Self Test Nasal Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific Antigen Self Test Nasal Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific Antigen Self Test Nasal Sales by Country (2021-2026) & (k units) Table 154. Asia Pacific Antigen Self Test Nasal Sales by Country (2027-2032) & (k units) Table 155. Asia Pacific Antigen Self Test Nasal Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific Antigen Self Test Nasal Revenue by Country (2027-2032) & (US$ Million) Table 157. South America Antigen Self Test Nasal Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America Antigen Self Test Nasal Sales by Country (2021-2026) & (k units) Table 159. South America Antigen Self Test Nasal Sales by Country (2027-2032) & (k units) Table 160. South America Antigen Self Test Nasal Revenue by Country (2021-2026) & (US$ Million) Table 161. South America Antigen Self Test Nasal Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Antigen Self Test Nasal Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa Antigen Self Test Nasal Sales by Country (2021-2026) & (k units) Table 164. Middle East and Africa Antigen Self Test Nasal Sales by Country (2027-2032) & (k units) Table 165. Middle East and Africa Antigen Self Test Nasal Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Antigen Self Test Nasal Revenue by Country (2027-2032) & (US$ Million) Table 167. Global Antigen Self Test Nasal Sales by Type (2021-2026) & (k units) Table 168. Global Antigen Self Test Nasal Sales by Type (2027-2032) & (k units) Table 169. Global Antigen Self Test Nasal Sales Market Share by Type (2021-2026) Table 170. Global Antigen Self Test Nasal Sales Market Share by Type (2027-2032) Table 171. Global Antigen Self Test Nasal Revenue by Type (2021-2026) & (US$ Million) Table 172. Global Antigen Self Test Nasal Revenue by Type (2027-2032) & (US$ Million) Table 173. Global Antigen Self Test Nasal Revenue Market Share by Type (2021-2026) Table 174. Global Antigen Self Test Nasal Revenue Market Share by Type (2027-2032) Table 175. Global Antigen Self Test Nasal Price by Type (2021-2026) & (USD/unit) Table 176. Global Antigen Self Test Nasal Price by Type (2027-2032) & (USD/unit) Table 177. Global Antigen Self Test Nasal Sales by Application (2021-2026) & (k units) Table 178. Global Antigen Self Test Nasal Sales by Application (2027-2032) & (k units) Table 179. Global Antigen Self Test Nasal Sales Market Share by Application (2021-2026) Table 180. Global Antigen Self Test Nasal Sales Market Share by Application (2027-2032) Table 181. Global Antigen Self Test Nasal Revenue by Application (2021-2026) & (US$ Million) Table 182. Global Antigen Self Test Nasal Revenue by Application (2027-2032) & (US$ Million) Table 183. Global Antigen Self Test Nasal Revenue Market Share by Application (2021-2026) Table 184. Global Antigen Self Test Nasal Revenue Market Share by Application (2027-2032) Table 185. Global Antigen Self Test Nasal Price by Application (2021-2026) & (USD/unit) Table 186. Global Antigen Self Test Nasal Price by Application (2027-2032) & (USD/unit) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Antigen Self Test Nasal Distributors List Table 190. Antigen Self Test Nasal Customers List Table 191. Antigen Self Test Nasal Industry Trends Table 192. Antigen Self Test Nasal Industry Drivers Table 193. Antigen Self Test Nasal Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Antigen Self Test Nasal Product Image Figure 5. Global Antigen Self Test Nasal Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Antigen Self Test Nasal Market Size (2021-2032) & (US$ Million) Figure 7. Global Antigen Self Test Nasal Sales (2021-2032) & (k units) Figure 8. Global Antigen Self Test Nasal Average Price (USD/unit) & (2021-2032) Figure 9. Colloidal Gold Immunochromatography Product Image Figure 10. Latex Immunochromatography Product Image Figure 11. Fluorescence Immunochromatography Product Image Figure 12. Others Product Image Figure 13. Hospital Product Image Figure 14. School Product Image Figure 15. Family Product Image Figure 16. Others Product Image Figure 17. Global Antigen Self Test Nasal Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Antigen Self Test Nasal, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Antigen Self Test Nasal Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Antigen Self Test Nasal Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Antigen Self Test Nasal Sales by Region in 2025 Figure 23. Global Antigen Self Test Nasal Revenue by Region in 2025 Figure 24. North America Antigen Self Test Nasal Market Size by Country in 2025 Figure 25. North America Antigen Self Test Nasal Sales Market Share by Country (2021-2032) Figure 26. North America Antigen Self Test Nasal Revenue Market Share by Country (2021-2032) Figure 27. United States Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Antigen Self Test Nasal Market Size by Country in 2025 Figure 31. Europe Antigen Self Test Nasal Sales Market Share by Country (2021-2032) Figure 32. Europe Antigen Self Test Nasal Revenue Market Share by Country (2021-2032) Figure 33. Germany Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Antigen Self Test Nasal Market Size by Country in 2025 Figure 44. Asia Pacific Antigen Self Test Nasal Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Antigen Self Test Nasal Revenue Market Share by Country (2021-2032) Figure 46. China Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Antigen Self Test Nasal Market Size by Country in 2025 Figure 55. South America Antigen Self Test Nasal Sales Market Share by Country (2021-2032) Figure 56. South America Antigen Self Test Nasal Revenue Market Share by Country (2021-2032) Figure 57. Brazil Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Colombia Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Antigen Self Test Nasal Market Size by Country in 2025 Figure 62. Middle East and Africa Antigen Self Test Nasal Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Antigen Self Test Nasal Revenue Market Share by Country (2021-2032) Figure 64. Egypt Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Antigen Self Test Nasal Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Antigen Self Test Nasal Sales Market Share by Type (2021-2032) Figure 70. Global Antigen Self Test Nasal Revenue Market Share by Type (2021-2032) Figure 71. Global Antigen Self Test Nasal Price (USD/unit) by Type (2021-2032) Figure 72. Global Antigen Self Test Nasal Sales Market Share by Application (2021-2032) Figure 73. Global Antigen Self Test Nasal Revenue Market Share by Application (2021-2032) Figure 74. Global Antigen Self Test Nasal Price (USD/unit) by Application (2021-2032) Figure 75. Antigen Self Test Nasal Value Chain Figure 76. Antigen Self Test Nasal Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Antigen Self Test Nasal Industry Opportunities and Challenges

Scope & coverage.

Types
  • Colloidal Gold Immunochromatography
  • Latex Immunochromatography
  • Fluorescence Immunochromatography
  • Others
Applications
  • Hospital
  • School
  • Family
  • Others
Companies covered
  • Roche
  • Watsons
  • TEST SEA LAB
  • SD Biosensor
  • RapiGEN Inc.
  • Rapid Labs Limited
  • Quidel
  • Princeton BioMeditech Corporation
  • Orient Gene
  • OraSure Technologies
  • LumiraDx
  • InBios
  • Heathershaws Compounding Pharmacy
  • Ellume
  • CTK Biotech
  • Clip Health
  • Celltrion
  • BioTeke Corporation
  • BGI
  • BD
  • Aidian Oy
  • ACCESS BIO
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Antigen Self Test Nasal Market Size (2021-2032)
  4. 2.2.2 Global Antigen Self Test Nasal Sales (2021-2032)
  5. 2.2.3 Global Antigen Self Test Nasal Market Average Price (2021-2032)
  6. 2.3 Antigen Self Test Nasal by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Colloidal Gold Immunochromatography
  9. 2.3.3 Latex Immunochromatography
  10. 2.3.4 Fluorescence Immunochromatography
  11. 2.3.5 Others
  12. 2.4 Antigen Self Test Nasal by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 School
  16. 2.4.4 Family
  17. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Antigen Self Test Nasal Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Antigen Self Test Nasal Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Antigen Self Test Nasal Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Antigen Self Test Nasal Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Antigen Self Test Nasal Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Antigen Self Test Nasal, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Antigen Self Test Nasal, Product Type & Application
  8. 3.8 Global Manufacturers of Antigen Self Test Nasal, Established Date
  9. 3.9 Global Antigen Self Test Nasal Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Roche
  2. 4.1.1 Roche Company Information
  3. 4.1.2 Roche Business Overview
  4. 4.1.3 Roche Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Roche Antigen Self Test Nasal Product Portfolio
  6. 4.1.5 Roche Recent Developments
  7. 4.2 Watsons
  8. 4.2.1 Watsons Company Information
  9. 4.2.2 Watsons Business Overview
  10. 4.2.3 Watsons Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Watsons Antigen Self Test Nasal Product Portfolio
  12. 4.2.5 Watsons Recent Developments
  13. 4.3 TEST SEA LAB
  14. 4.3.1 TEST SEA LAB Company Information
  15. 4.3.2 TEST SEA LAB Business Overview
  16. 4.3.3 TEST SEA LAB Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 TEST SEA LAB Antigen Self Test Nasal Product Portfolio
  18. 4.3.5 TEST SEA LAB Recent Developments
  19. 4.4 SD Biosensor
  20. 4.4.1 SD Biosensor Company Information
  21. 4.4.2 SD Biosensor Business Overview
  22. 4.4.3 SD Biosensor Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 SD Biosensor Antigen Self Test Nasal Product Portfolio
  24. 4.4.5 SD Biosensor Recent Developments
  25. 4.5 RapiGEN Inc.
  26. 4.5.1 RapiGEN Inc. Company Information
  27. 4.5.2 RapiGEN Inc. Business Overview
  28. 4.5.3 RapiGEN Inc. Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 RapiGEN Inc. Antigen Self Test Nasal Product Portfolio
  30. 4.5.5 RapiGEN Inc. Recent Developments
  31. 4.6 Rapid Labs Limited
  32. 4.6.1 Rapid Labs Limited Company Information
  33. 4.6.2 Rapid Labs Limited Business Overview
  34. 4.6.3 Rapid Labs Limited Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Rapid Labs Limited Antigen Self Test Nasal Product Portfolio
  36. 4.6.5 Rapid Labs Limited Recent Developments
  37. 4.7 Quidel
  38. 4.7.1 Quidel Company Information
  39. 4.7.2 Quidel Business Overview
  40. 4.7.3 Quidel Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Quidel Antigen Self Test Nasal Product Portfolio
  42. 4.7.5 Quidel Recent Developments
  43. 4.8 Princeton BioMeditech Corporation
  44. 4.8.1 Princeton BioMeditech Corporation Company Information
  45. 4.8.2 Princeton BioMeditech Corporation Business Overview
  46. 4.8.3 Princeton BioMeditech Corporation Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Princeton BioMeditech Corporation Antigen Self Test Nasal Product Portfolio
  48. 4.8.5 Princeton BioMeditech Corporation Recent Developments
  49. 4.9 Orient Gene
  50. 4.9.1 Orient Gene Company Information
  51. 4.9.2 Orient Gene Business Overview
  52. 4.9.3 Orient Gene Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Orient Gene Antigen Self Test Nasal Product Portfolio
  54. 4.9.5 Orient Gene Recent Developments
  55. 4.10 OraSure Technologies
  56. 4.10.1 OraSure Technologies Company Information
  57. 4.10.2 OraSure Technologies Business Overview
  58. 4.10.3 OraSure Technologies Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 OraSure Technologies Antigen Self Test Nasal Product Portfolio
  60. 4.10.5 OraSure Technologies Recent Developments
  61. 4.11 LumiraDx
  62. 4.11.1 LumiraDx Company Information
  63. 4.11.2 LumiraDx Business Overview
  64. 4.11.3 LumiraDx Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 LumiraDx Antigen Self Test Nasal Product Portfolio
  66. 4.11.5 LumiraDx Recent Developments
  67. 4.12 InBios
  68. 4.12.1 InBios Company Information
  69. 4.12.2 InBios Business Overview
  70. 4.12.3 InBios Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 InBios Antigen Self Test Nasal Product Portfolio
  72. 4.12.5 InBios Recent Developments
  73. 4.13 Heathershaws Compounding Pharmacy
  74. 4.13.1 Heathershaws Compounding Pharmacy Company Information
  75. 4.13.2 Heathershaws Compounding Pharmacy Business Overview
  76. 4.13.3 Heathershaws Compounding Pharmacy Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Heathershaws Compounding Pharmacy Antigen Self Test Nasal Product Portfolio
  78. 4.13.5 Heathershaws Compounding Pharmacy Recent Developments
  79. 4.14 Ellume
  80. 4.14.1 Ellume Company Information
  81. 4.14.2 Ellume Business Overview
  82. 4.14.3 Ellume Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Ellume Antigen Self Test Nasal Product Portfolio
  84. 4.14.5 Ellume Recent Developments
  85. 4.15 CTK Biotech
  86. 4.15.1 CTK Biotech Company Information
  87. 4.15.2 CTK Biotech Business Overview
  88. 4.15.3 CTK Biotech Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 CTK Biotech Antigen Self Test Nasal Product Portfolio
  90. 4.15.5 CTK Biotech Recent Developments
  91. 4.16 Clip Health
  92. 4.16.1 Clip Health Company Information
  93. 4.16.2 Clip Health Business Overview
  94. 4.16.3 Clip Health Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Clip Health Antigen Self Test Nasal Product Portfolio
  96. 4.16.5 Clip Health Recent Developments
  97. 4.17 Celltrion
  98. 4.17.1 Celltrion Company Information
  99. 4.17.2 Celltrion Business Overview
  100. 4.17.3 Celltrion Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Celltrion Antigen Self Test Nasal Product Portfolio
  102. 4.17.5 Celltrion Recent Developments
  103. 4.18 BioTeke Corporation
  104. 4.18.1 BioTeke Corporation Company Information
  105. 4.18.2 BioTeke Corporation Business Overview
  106. 4.18.3 BioTeke Corporation Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 BioTeke Corporation Antigen Self Test Nasal Product Portfolio
  108. 4.18.5 BioTeke Corporation Recent Developments
  109. 4.19 BGI
  110. 4.19.1 BGI Company Information
  111. 4.19.2 BGI Business Overview
  112. 4.19.3 BGI Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 BGI Antigen Self Test Nasal Product Portfolio
  114. 4.19.5 BGI Recent Developments
  115. 4.20 BD
  116. 4.20.1 BD Company Information
  117. 4.20.2 BD Business Overview
  118. 4.20.3 BD Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 BD Antigen Self Test Nasal Product Portfolio
  120. 4.20.5 BD Recent Developments
  121. 4.21 Aidian Oy
  122. 4.21.1 Aidian Oy Company Information
  123. 4.21.2 Aidian Oy Business Overview
  124. 4.21.3 Aidian Oy Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Aidian Oy Antigen Self Test Nasal Product Portfolio
  126. 4.21.5 Aidian Oy Recent Developments
  127. 4.22 ACCESS BIO
  128. 4.22.1 ACCESS BIO Company Information
  129. 4.22.2 ACCESS BIO Business Overview
  130. 4.22.3 ACCESS BIO Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 ACCESS BIO Antigen Self Test Nasal Product Portfolio
  132. 4.22.5 ACCESS BIO Recent Developments
  133. 4.23 Abbott
  134. 4.23.1 Abbott Company Information
  135. 4.23.2 Abbott Business Overview
  136. 4.23.3 Abbott Antigen Self Test Nasal Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Abbott Antigen Self Test Nasal Product Portfolio
  138. 4.23.5 Abbott Recent Developments
5 Global Antigen Self Test Nasal Market Scenario by Region
  1. 5.1 Global Antigen Self Test Nasal Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Antigen Self Test Nasal Sales by Region: 2021-2032
  3. 5.2.1 Global Antigen Self Test Nasal Sales by Region: 2021-2026
  4. 5.2.2 Global Antigen Self Test Nasal Sales by Region: 2027-2032
  5. 5.3 Global Antigen Self Test Nasal Revenue by Region: 2021-2032
  6. 5.3.1 Global Antigen Self Test Nasal Revenue by Region: 2021-2026
  7. 5.3.2 Global Antigen Self Test Nasal Revenue by Region: 2027-2032
  8. 5.4 North America Antigen Self Test Nasal Market Facts & Figures by Country
  9. 5.4.1 North America Antigen Self Test Nasal Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Antigen Self Test Nasal Sales by Country (2021-2032)
  11. 5.4.3 North America Antigen Self Test Nasal Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Antigen Self Test Nasal Market Facts & Figures by Country
  16. 5.5.1 Europe Antigen Self Test Nasal Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Antigen Self Test Nasal Sales by Country (2021-2032)
  18. 5.5.3 Europe Antigen Self Test Nasal Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Antigen Self Test Nasal Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Antigen Self Test Nasal Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Antigen Self Test Nasal Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Antigen Self Test Nasal Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Antigen Self Test Nasal Market Facts & Figures by Country
  41. 5.7.1 South America Antigen Self Test Nasal Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Antigen Self Test Nasal Sales by Country (2021-2032)
  43. 5.7.3 South America Antigen Self Test Nasal Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Antigen Self Test Nasal Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Antigen Self Test Nasal Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Antigen Self Test Nasal Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Antigen Self Test Nasal Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Antigen Self Test Nasal Sales by Type (2021-2032)
  2. 6.1.1 Global Antigen Self Test Nasal Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Antigen Self Test Nasal Sales Market Share by Type (2021-2032)
  4. 6.2 Global Antigen Self Test Nasal Revenue by Type (2021-2032)
  5. 6.2.1 Global Antigen Self Test Nasal Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Antigen Self Test Nasal Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Antigen Self Test Nasal Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Antigen Self Test Nasal Sales by Application (2021-2032)
  2. 7.1.1 Global Antigen Self Test Nasal Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Antigen Self Test Nasal Sales Market Share by Application (2021-2032)
  4. 7.2 Global Antigen Self Test Nasal Revenue by Application (2021-2032)
  5. 7.2.1 Global Antigen Self Test Nasal Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Antigen Self Test Nasal Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Antigen Self Test Nasal Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Antigen Self Test Nasal Value Chain Analysis
  2. 8.1.1 Antigen Self Test Nasal Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Antigen Self Test Nasal Production Mode & Process
  5. 8.2 Antigen Self Test Nasal Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Antigen Self Test Nasal Distributors
  8. 8.2.3 Antigen Self Test Nasal Customers
9 Global Antigen Self Test Nasal Analyzing Market Dynamics
  1. 9.1 Antigen Self Test Nasal Industry Trends
  2. 9.2 Antigen Self Test Nasal Industry Drivers
  3. 9.3 Antigen Self Test Nasal Industry Opportunities and Challenges
  4. 9.4 Antigen Self Test Nasal Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst